Therapeutic Agents 812

Erik Johansson Kjell; Martin Birch Alan; Hanna De La Motte; John Butlin Roger; Stephen Clarke David; Andrew Leach; Alexander MacFaul Philip; John O'Donnell Charles; Stewart Scott James; Owen Whittamore Paul Robert; Anders Broo Dan; Percy Davidsson Oejvind

Therapeutic Agents 812

Erik Johansson Kjell (Inventor), Martin Birch Alan (Inventor), Hanna De La Motte (Inventor), John Butlin Roger (Inventor), Stephen Clarke David (Inventor), Andrew Leach (Inventor), Alexander MacFaul Philip (Inventor), John O'Donnell Charles (Inventor), Stewart Scott James (Inventor), Owen Whittamore Paul Robert (Inventor), Anders Broo Dan (Inventor), Percy Davidsson Oejvind (Inventor)

Pharmacy

AstraZeneca plc

Research output: Patent

Abstract

A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as GPR119 modulators, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, and pharmaceutical compositions containing them.

Original language	English
Patent number	US2011065706
IPC	C07D 487/ 08 A I
Priority date	10/09/10
Publication status	Published - 17 Mar 2011

Cite this

@misc{8f9e6dee005443bb90282e86f01a5540,

title = "Therapeutic Agents 812",

abstract = "A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as GPR119 modulators, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, and pharmaceutical compositions containing them.",

author = "{Johansson Kjell}, Erik and {Birch Alan}, Martin and {De La Motte}, Hanna and {Butlin Roger}, John and {Clarke David}, Stephen and Andrew Leach and {MacFaul Philip}, Alexander and {O'Donnell Charles}, John and {Scott James}, Stewart and {Whittamore Paul Robert}, Owen and {Broo Dan}, Anders and {Davidsson Oejvind}, Percy",

year = "2011",

month = mar,

day = "17",

language = "English",

type = "Patent",

note = "US2011065706; C07D 487/ 08 A I",

}

TY - PAT

T1 - Therapeutic Agents 812

AU - Johansson Kjell, Erik

AU - Birch Alan, Martin

AU - De La Motte, Hanna

AU - Butlin Roger, John

AU - Clarke David, Stephen

AU - Leach, Andrew

AU - MacFaul Philip, Alexander

AU - O'Donnell Charles, John

AU - Scott James, Stewart

AU - Whittamore Paul Robert, Owen

AU - Broo Dan, Anders

AU - Davidsson Oejvind, Percy

PY - 2011/3/17

Y1 - 2011/3/17

N2 - A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as GPR119 modulators, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, and pharmaceutical compositions containing them.

AB - A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as GPR119 modulators, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, and pharmaceutical compositions containing them.

M3 - Patent

M1 - US2011065706

ER -

Therapeutic Agents 812

Abstract

Fingerprint

Cite this